Dr. Opremcak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Neil Ave
Suite 220
Columbus, OH 43215Phone+1 614-464-3937Fax+1 614-464-0088
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1985 - 1986
- Ohio State University HospitalResidency, Ophthalmology, 1982 - 1985
- OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1981 - 1982
- Ohio State University College of MedicineClass of 1981
Certifications & Licensure
- OH State Medical License 1982 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 35 citationsTrimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.E. Mitchel Opremcak, David K. Scales, Matthew R. Sharpe
Ophthalmology. 1992-06-01 - 53 citationsOcular Toxoplasmosis Misdiagnosed as Cytomegalovirus Retinopathy in Immunocompromised PatientsBrad S. Elkins, Gary N. Holland, E. Mitchel Opremcak, James P. Dunn, Douglas A. Jabs
Ophthalmology. 1994-03-01 - 4 citationsPanretinal acute multifocal placoid pigment epitheliopathy: a novel posterior uveitis syndrome with HLA-A3 and HLA-C7 associationKevin R. Baxter, E. Mitchel Opremcak
Journal of Ophthalmic Inflammation and Infection. 2013-02-04
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: